Birmingham Health Innovation Campus (BHIC)

Client Name: Bruntwood SciTech

Role: Employer's Agent and Cost Manager


Birmingham Health Innovation Campus (BHIC) is being developed by Bruntwood SciTech, a collaboration between Bruntwood and Legal & General, and is set to become a world-leading life sciences campus. Due to open in 2023, it will offer high-quality laboratory, office, incubation and innovation facilities for forward-thinking businesses and will be part of an integrated, physically connected critical cluster of patient-centred health excellence.

A 10-year master plan has been developed for the Campus, which will provide up to 700,000 sq. ft. of the state-of-the-art lab, office and incubation space acting as a catalyst for the growth of the Midlands’ life sciences sector. It is set to create over 10,000 new jobs.

The campus will provide cutting-edge innovation facilities, building on our nationally recognised strengths in healthcare data, genomics medicine and diagnostics, medical technologies and clinical trials.

RLF has been an integral part of the team from inception and worked alongside Bruntwood SciTech and the University of Birmingham to develop a master plan of exceptional quality.

Precision Health Technologies Accelerator

This signature facility will be the focal point of the development, providing up to 6,000 sqm of innovation, co-creation and incubation space within the Phase 1 building.

The PHTA will be dedicated to the rapid development and translation of innovative therapies and technologies from concept to clinical evaluation. By creating new opportunities for businesses and entrepreneurs to innovate and grow, and for clinical academics in the region to commercialise their ideas, will accelerate our ambition to be a research and innovation leader in health and life sciences.

The PHTA will provide the early incubation, grow-on space and innovation services for businesses working across biopharma, advanced therapies, diagnostics, digital health and healthcare technologies to accelerate the development and delivery of new drugs, diagnostics and devices into the clinic. Its incubation services for early-stage businesses are set to include wet labs, dry labs and office spaces, and prototype development facilities.